Stay updated with breaking news from Outsourcing Facilities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In recent years, various federal agencies, including the Department of Health and Human Services Office of the Inspector General and the U.S. Food and Drug Administration (FDA), have...
Provider and Patient Access to Key Therapies Expected to ImproveWASHINGTON--(BUSINESS WIRE)--The Outsourcing Facilities Association (OFA) today announced that it has reached a settlement agreement with the U.S. Food and Drug Administration that spurs the FDA to promptly review long-pending nominations for active pha...
Dublin, March 23, 2022 (GLOBE NEWSWIRE) -- The "Sterile Compounding Pharmacies Market Forecast to 2028" report has been added to ResearchAndMarkets.com's...
A comprehensive domestically oriented supply chain would alleviate drug shortages and create a less vulnerable and potentially more efficient model....
Share this article Share this article ResearchAndMarkets.com's offering. The compounding pharmacies market was valued at US$ 9,442.8 million in 2020 and is projected to reach US$ 14,995.1 million by 2028; it is expected to grow at a CAGR of 6.1% from 2021 to 2028. Drug shortage crisis across the world, benefits associated with compounded medications, and increasing adoption of customized medicine (Personalized medicine) are among the major factors fueling the market growth. Moreover, growing demand for compounding pharmacy during COVID-19 are expected to foster the market growth during the fo...